Canada markets closed

Bausch Health Companies Inc. (BHC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
18.36+0.36 (+2.00%)
At close: 4:00PM EDT
Sign in to post a message.
  • F
    Fred
    June 2014: "Financially Troubled Dendreon Corporation Loses Its CEO"?
    Oct 2019: "Thrilled to announce early close of our P3 ProVent trial . Will immunotherapy redefine the way early-stage prostate cancer is treated? We think so!"?

    Yikes.
  • J
    Jeffrey
    This has got to be said right now at 2:46 p.m. Hawaii time.
    ICM= Ice Cream Matters
  • F
    Fred
    1: July 2010: "Prostate cancer vaccine, Provenge, adds 4 months to life, at a $100K pricetag."?
    2: Jan 2017: " Perhaps most surprisingly, the notorious Dendreon is among the assets that have found a buyer, in the shape of a private Chinese conglomerate, Sanpower – for $820m. Of course it is not immediately clear how much Valeant had invested in Dendreon, but the fact it had paid only $495m for it two years ago suggests that, against the odds, it found a way to make a profit out of this business."?
    3: Oct 2019: "Thrilled to announce early close of our P3 ProVent trial . Will immunotherapy redefine the way early-stage prostate cancer is treated? We think so!"?
    4: July 2020: "Nearly 4 Year Median OS in Men with Low PSA"?

    Ridiculous storytelling.. IMHO
    Dendreon is really worth many Billions of Dollars. IMHO
  • H
    Helmut
    I muted all, but j
  • J
    Jeffrey
    Hi bhc'ers. Losses and Debt report release soon. Colossal debt. Epic losses.
  • F
    Fred
    1: July 2010: "Prostate cancer vaccine, Provenge, adds 4 months to life, at a $100K pricetag."?
    2: June 2014: "But Dendreon is looking for Johnson's successor, and Douglas Watson is the flailing company's new chairman. The survivors are optimistic that the company will still succeed. "?
    3: July 2020: "Nearly 4 Year Median OS in Men with Low PSA"?

    What a game that was played on us. IMHO
  • F
    Fred
    Johnson & Johnson & "John Johnson"?
    1: July 2010: "Prostate cancer vaccine, Provenge, adds 4 months to life, at a $100K pricetag."?
    2: Nov 2014: "He adds: “On behalf of the board, I would like to thank John for his leadership, dedication, and passion for helping prostate cancer patients live longer and better lives through Provenge.”"?
    3: Jan 2019: " Zytiga is still romping away, with a 40% gain in the year to $3.5 billion"?
    But, But, But
    4: July 2020: "Nearly 4 Year Median OS in Men with Low PSA"?

    Hmmm
  • F
    Fred
    DENDREON:
    1: July 2010: "Prostate cancer vaccine, Provenge, adds 4 months to life, at a $100K pricetag."?
    2: June 2014: "Despite the reduction in losses, revenues fell to $283.7 million from $325.3 million a year earlier. "?
    3: July 2020: "Nearly 4 Year Median OS in Men with Low PSA"?

    DNDN shareholders were Grossly Cheated. IMHO

    All they had to do was tell the truth about Provenge, and Sales would have skyrocketed. IMHO

    But Big Pharma didn't want the truth to get out. IMHO
  • J
    Jeffrey
    This has got to be said right now at 2:46 p.m. Hawaii time.
    ICM= Ice Cream Matters
  • J
    Jeffrey
    Been with a 10 galleon drum of extra marshmellow rocky road since 5:30am Hawaii time. What happened ?
  • J
    Jeffrey
    Joe Papa's BIG PLAN for BHC's future is to open Ice Cream Shops all over the world.
  • d
    don't worry be happy
    No volume. No takers.
  • A
    Al
    between meals
  • F
    Fred
    Jan 2017: " Perhaps most surprisingly, the notorious Dendreon is among the assets that have found a buyer, in the shape of a private Chinese conglomerate, Sanpower – for $820m. Of course it is not immediately clear how much Valeant had invested in Dendreon, but the fact it had paid only $495m for it two years ago suggests that, against the odds, it found a way to make a profit out of this business."?
    But, But, But
    Aug 2020: "Urologists and others treating prostate cancer are living in a prostate cancer “revolution”. Five to seven years ago, it didn’t seem possible that men with mCRPC could live two years after their diagnosis, and now real-world data is showing us it may be as long as four years or longer if immunotherapy is used when PSA levels are lower and likely to offer the most benefit."?

    Yikes. The Bausch Health Company Inc. people really got taken on that deal. IMO
    Dendreon is really worth many Billions of Dollars. IMHO

    And where's Neuvenge?
  • R
    Ravi
    When this company is going to deliver the profits? BHC has no idea when it will be profitable. In last so many years there were only positive announcements on new developments but net results are a big losses every year.
  • F
    Fred
    pay up
  • J
    Jeffrey
    Papa is on his 4-hour lunch break now, then Papa takes a nap, then Papa goes back to the Chinese buffett for dinner.
  • d
    don't worry be happy
    lol
  • F
    Fred
    1: Apr 2012: "Conceptually it makes sense that with Provenge, an immune therapy, earlier use is better. If you look at our New England Journal paper and look at prognostic factors, overall there was a trend when people had lower disease burden and lower PSAs, there tends to be a bigger benefit for Provenge. We’re digging into that some more."?
    ---------------------------------------------------------------------------------------------------------
    2: Nov 2014: "Dendreon Files for Bankruptcy as Cancer Drug Disappoints"?
    3: Jan 2019: " Zytiga is still romping away, with a 40% gain in the year to $3.5 billion"?
    ---------------------------------------------------------------------------------------------------------
    4: Aug 2020: "Urologists and others treating prostate cancer are living in a prostate cancer “revolution”. Five to seven years ago, it didn’t seem possible that men with mCRPC could live two years after their diagnosis, and now real-world data is showing us it may be as long as four years or longer if immunotherapy is used when PSA levels are lower and likely to offer the most benefit."?

    2020 - 2012 = 8 years
    Seriously?
  • G
    Gladiator
    Huge debt